|
AU712012B2
(en)
*
|
1995-09-26 |
1999-10-28 |
Toray Industries, Inc. |
Indole derivatives and medical application thereof
|
|
EP0894799B1
(en)
*
|
1997-01-16 |
2004-04-07 |
Toray Industries, Inc. |
Indolomorphinane derivatives and remedies/preventives for cerebral disorders
|
|
GB9717629D0
(en)
*
|
1997-08-21 |
1997-10-22 |
Johnson Matthey Plc |
Removal of residual organic solvents
|
|
US6500824B1
(en)
*
|
1998-08-06 |
2002-12-31 |
Regents Of The University Of Minnesota |
Kappa (OP2) opioid receptor antagonists
|
|
WO2002080919A1
(en)
*
|
2001-04-06 |
2002-10-17 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
US7232829B2
(en)
|
2001-04-06 |
2007-06-19 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
DE10229842A1
(de)
*
|
2002-07-03 |
2004-02-05 |
Helmut Prof. Dr. Schmidhammer |
Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
|
|
AU2004278414B2
(en)
|
2003-10-01 |
2012-05-24 |
Adolor Corporation |
Spirocyclic heterocyclic derivatives and methods of their use
|
|
US7598261B2
(en)
|
2005-03-31 |
2009-10-06 |
Adolor Corporation |
Spirocyclic heterocyclic derivatives and methods of their use
|
|
US7576207B2
(en)
|
2006-04-06 |
2009-08-18 |
Adolor Corporation |
Spirocyclic heterocyclic derivatives and methods of their use
|
|
EP2399577A1
(en)
|
2006-09-12 |
2011-12-28 |
Adolor Corporation |
Use of N-containing spirocompounds for the enhancement of cognitive function
|
|
US9321116B2
(en)
*
|
2009-03-05 |
2016-04-26 |
United Technologies Corporation |
Cold metal transfer gas metal arc welding apparatus and method of operation
|
|
EP2340832A1
(en)
|
2009-12-23 |
2011-07-06 |
Universität Innsbruck |
Morphinan-6-one compounds for the treatment or prevention of neurodegenerative diseases
|
|
ES2604931T3
(es)
|
2010-12-23 |
2017-03-10 |
Phoenix Pharmalabs, Inc. |
Nuevos morfinanos útiles como analgésicos
|
|
US9303038B2
(en)
|
2011-09-06 |
2016-04-05 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of epilepsy and neurological diseases
|
|
WO2013167990A1
(en)
|
2012-05-07 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of depression
|
|
SG11201407300VA
(en)
|
2012-05-07 |
2014-12-30 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of neurological disorders
|
|
WO2013168021A1
(en)
|
2012-05-07 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
|
|
US9309233B2
(en)
|
2012-05-08 |
2016-04-12 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of blood clotting disorders
|
|
US9403826B2
(en)
|
2012-05-08 |
2016-08-02 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of inflammatory disorders
|
|
US9266823B2
(en)
|
2012-05-08 |
2016-02-23 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of parkinson's disease
|
|
WO2013167993A1
(en)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of neurological degenerative disorders
|
|
US9522884B2
(en)
|
2012-05-08 |
2016-12-20 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of metabolic disorders
|
|
WO2013167997A2
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of metabolic syndrome
|
|
US9273061B2
(en)
|
2012-05-10 |
2016-03-01 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of chronic pain
|
|
US9573927B2
(en)
|
2012-05-10 |
2017-02-21 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of severe pain
|
|
WO2013168015A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of asthma and allergy
|
|
US9346742B2
(en)
|
2012-05-10 |
2016-05-24 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of fibromyalgia pain
|
|
US9499526B2
(en)
|
2012-05-10 |
2016-11-22 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurologic diseases
|
|
WO2013167999A2
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of neurologic diseases
|
|
WO2013168014A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of familial amyloid polyneuropathy
|
|
WO2013168001A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of moderate to severe pain
|
|
US9242939B2
(en)
|
2012-05-10 |
2016-01-26 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of respiratory disorders
|
|
US9403857B2
(en)
|
2012-05-10 |
2016-08-02 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of metabolic syndrome
|
|
US9233161B2
(en)
|
2012-05-10 |
2016-01-12 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological conditions
|
|
US9339484B2
(en)
|
2012-05-10 |
2016-05-17 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
|
|
SG11201407326XA
(en)
|
2012-05-23 |
2014-12-30 |
Cellix Bio Private Ltd |
Compositions and methods for treatment of mucositis
|
|
US9434729B2
(en)
|
2012-05-23 |
2016-09-06 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
|
|
NZ701832A
(en)
|
2012-05-23 |
2016-08-26 |
Cellix Bio Private Ltd |
Compositions and methods for treatment of inflammatory bowel disease
|
|
WO2013175347A2
(en)
|
2012-05-23 |
2013-11-28 |
Mahesh Kandula |
Compositions and methods for the treatment of respiratory disorders
|
|
WO2013175376A2
(en)
|
2012-05-23 |
2013-11-28 |
Mahesh Kandula |
Compositions and methods for the treatment of local pain
|
|
JP2015518854A
(ja)
|
2012-05-23 |
2015-07-06 |
セリックスビオ プライヴェート リミテッド |
多発性硬化症の治療のための組成物および方法
|
|
US9108942B1
(en)
|
2014-11-05 |
2015-08-18 |
Mahesh Kandula |
Compositions and methods for the treatment of moderate to severe pain
|
|
US9187427B2
(en)
|
2012-08-03 |
2015-11-17 |
Cellix Bio Private Limited |
N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases
|
|
WO2014037833A2
(en)
|
2012-09-06 |
2014-03-13 |
Mahesh Kandula |
Compositions and methods for the treatment inflammation and lipid disorders
|
|
AU2013311349A1
(en)
|
2012-09-08 |
2014-11-27 |
Cellixbio Private Limited |
Compositions and methods for treatment of inflammation and lipid disorders
|
|
HU231191B1
(hu)
|
2013-04-15 |
2021-08-30 |
Szegedi Tudományegyetem |
Izotóp tartalmú morfin molekulák
|
|
US9333187B1
(en)
|
2013-05-15 |
2016-05-10 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of inflammatory bowel disease
|
|
AU2014276346A1
(en)
|
2013-06-04 |
2015-12-24 |
Cellixbio Private Limited |
Compositions and methods for the treatment of diabetes and pre-diabetes
|
|
ES2784690T3
(es)
|
2013-12-05 |
2020-09-29 |
Univ Bath |
Nuevos compuestos opioides y sus usos
|
|
US9096537B1
(en)
|
2014-12-31 |
2015-08-04 |
Mahesh Kandula |
Compositions and methods for the treatment of mucositis
|
|
SG11201706952VA
(en)
|
2014-09-26 |
2017-10-30 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of epilepsy and neurological disorders
|
|
EP3201168B1
(en)
|
2014-09-29 |
2020-03-18 |
Cellix Bio Private Limited |
Compounds and compositions for the treatment of multiple sclerosis
|
|
AU2014414316B2
(en)
|
2014-10-27 |
2020-04-09 |
Cellix Bio Private Limited |
Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
|
|
US10208014B2
(en)
|
2014-11-05 |
2019-02-19 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological disorders
|
|
US9173877B1
(en)
|
2014-11-05 |
2015-11-03 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of local pain
|
|
US9150557B1
(en)
|
2014-11-05 |
2015-10-06 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of hyperglycemia
|
|
US9321716B1
(en)
|
2014-11-05 |
2016-04-26 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of metabolic syndrome
|
|
US9284287B1
(en)
|
2014-11-05 |
2016-03-15 |
Cellix Bio Private Limited |
Compositions and methods for the suppression of carbonic anhydrase activity
|
|
US9175008B1
(en)
|
2014-11-05 |
2015-11-03 |
Cellix Bio Private Limited |
Prodrugs of anti-platelet agents
|
|
US9290486B1
(en)
|
2014-11-05 |
2016-03-22 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of epilepsy
|
|
ES2787223T3
(es)
|
2014-11-07 |
2020-10-15 |
Univ Minnesota |
Sales y composiciones útiles para tratar enfermedades
|
|
WO2016088132A1
(en)
|
2014-12-01 |
2016-06-09 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of multiple sclerosis
|
|
US9206111B1
(en)
|
2014-12-17 |
2015-12-08 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological diseases
|
|
JP6679616B2
(ja)
|
2015-01-06 |
2020-04-22 |
セリックス バイオ プライヴェート リミテッドＣｅｌｌｉｘ Ｂｉｏ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ |
炎症及び疼痛の治療のための組成物及び方法
|
|
CA3018750A1
(en)
|
2016-03-22 |
2017-09-28 |
Regents Of The University Of Minnesota |
Combination for treating pain
|